Global Phenylketonuria Treatment Market Is Estimated To Witness High Growth Owing To BioMarin Pharmaceutical Inc. and Dimension Therapeutics Inc.
The global Phenylketonuria (PKU) treatment market is estimated to be valued at Usd 610.3 Million In 2022 and is expected to exhibit a CAGR Of 6.2% over the forecast period 2022-2032, as highlighted in a new report published by Coherent Market Insights.Market Overview:Phenylketonuria is a genetic metabolic disorder that affects the body's ability to break down the amino acid phenylalanine. If...
0 Comments 0 Shares 1317 Views 0 Reviews
Sponsored